SpringWorks Therapeutics Novice Eulerpool

SpringWorks Therapeutics Novice o delnici

SpringWorks Therapeutics spremljajo številni novinarji in vlagatelji po vsem svetu. Najnovejše SpringWorks Therapeutics novice zbiramo in objavljamo tukaj.

• 19. avgust ·

  Yahoo
  Merck announces EC approval of Ogsiveo for desmoid tumours
• 18. avgust ·

  Yahoo
  European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
• 15. avgust ·

  Yahoo
  Merck KGaA ventures into new territory in the US
• 18. julij ·

  Yahoo
  European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
• 2. julij ·

  Yahoo
  Merck concludes SpringWorks acquisition for $3.4bn
• 1. julij ·

  Yahoo
  Merck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business
• 20. junij ·

  Yahoo
  SpringWorks Therapeutics Receives Positive CHMP Opinion for Nirogacestat for the Treatment of Adults with Desmoid Tumors
• 28. maj ·

  SeekingAlpha
  Carillon Eagle Small Cap Growth Fund Q1 2025 Commentary
• 27. maj ·

  Yahoo
  High Growth Tech Stocks in the US to Watch This May 2025
• 23. maj ·

  Yahoo
  SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN